BoB Settles Landmark $600 Million Case with NMC Health, Ending Major Overseas Legal Saga

BoB Settles Landmark $600 Million Case with NMC Health, Ending Major Overseas Legal Saga​

Bank of Baroda (BoB) has reached a historic out-of-court settlement amounting to $600 million, or approximately Rs 5,700 crore. This agreement resolves one of the longest and most complex overseas legal disputes involving an Indian banking institution. The payment was made to NMC Health, a healthcare entity based in the UAE that is now under joint administration after undergoing insolvency proceedings.

The settlement, detailed in a July 2 exchange filing, brought to a close a dispute that spanned multiple jurisdictions. Importantly, the agreement stipulates that neither party admits any liability or wrongdoing. This move aims simply to conclude the matter and avoid prolonged litigation, associated costs, and uncertainty.

Financial Impact of the Dispute Settlement on Bank of Baroda​

The settlement comes as a stark contrast to BoB’s previous filings regarding its legal defenses. The bank had previously stated in its annual report for fiscal year 2026 that it possessed robust internal mechanisms to defend against similar allegations, and consequently, had not made any provision for potential liability.

However, the decision to pay the $600 million amount represents a resolution of a significant legal overhang. Sources indicate that while this dispute was massive in quantum, the bank previously believed it had reasonable grounds to challenge the jurisdictional ruling of the ADGM Court of Appeal from July 2024.

Analyst estimates suggest a measurable impact on BoB’s first-quarter profit announcement later this month. One report cited by Hindu Businessline indicated that the settlement could result in a loss to post-tax profit amounting to approximately Rs 4,300 crore. This figure, if realized, has the potential to wipe out at least 30 percent of the profit anticipated for FY26.

Grounds of Accusation Against BoB in NMC Health Case​

The litigation against BoB originated from civil and insolvency proceedings handled before the Abu Dhabi Global Market Court of First Instance and the High Court of Justice of England and Wales. The joint administrators of NMC Health, NMC Healthcare, and NMC Holding leveled accusations concerning operations conducted by BoB’s Abu Dhabi branch.

Administrators accused the bank of engaging in certain questionable financial agreements. These allegations suggested that BoB processed transactions and extended banking facilities without conducting adequate due diligence or performing necessary Anti-Money Laundering (AML) checks and Know Your Customer (KYC) procedures.

The joint administrators alleged that BoB’s activities assisted NMC in concealing its true financial position, directly contributing to losses suffered by various creditors. Though the bank maintained it acted lawfully, maintaining that failure regarding AML was "far-fetched," it faced these serious accusations.

The Trajectory of NMC Health and Its Decline​

NMC Health, which was founded in 1975 by Indian pharmacist BR Shetty, rose to become a preeminent private healthcare provider across the UAE. It achieved significant milestones, including listing on the London Stock Exchange (LSE) in 2012 and being included in the FTSE 100 Index in 2018. At its peak, the company was valued at over $10 billion.

NMC Health experienced a severe downturn starting in December 2019. This period followed a short-seller report by US investment research firm Muddy Waters. The report alleged that NMC had overstated cash balances and understated debt through excessive spending on capital expenditures and acquisitions.

An independent review conducted in February 2020 substantiated the claims, revealing that the company had misrepresented its debt position. Following this revelation, NMC was placed under joint administration by Alvarez & Marsal, and trading of shares was suspended.